Starting in 2029, some drugs from small biotech companies would be left out of Medicare price talks. Companies must meet yearly rules for size, research spending, and foreign ties.
Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Small Biotech Innovation Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Finance.
Latest action on S. 1930: Read twice and referred to the Committee on Finance.
Who this affects: This bill mainly affects small biotech companies with drugs that Medicare could choose for price talks. Qualifying firms could keep those drugs out of the program, but they would face yearly paperwork and strict research spending rules. Medicare and its members could also feel the effects. Their costs would depend on which drugs receive the exception and how many companies qualify.
Why this matters: Medicare may pay more when it cannot negotiate a drug's price. This bill could remove some small biotech drugs from those talks. Qualifying companies could keep more revenue for research or other uses. However, Medicare and its members could lose possible savings. The final effect is uncertain because it depends on which companies and drugs qualify.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Keep acting on Modern Action
Compare the broader issue and related bills without leaving Modern Action.
Officially: Small Biotech Innovation Act
Starting in 2029, some drugs from small biotech companies would be left out of Medicare price talks. Companies must meet yearly rules for size, research spending, and foreign ties.
Use this page to support, oppose, or ask Congress to amend S1930. Modern Action explains what the bill does, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Sitting in Finance
No vote scheduled. Constituent contact is what moves bills out of committee.
↓ Why your message matters here
This bill is sitting in committee with no scheduled vote — which means a small number of constituent messages can decide whether it moves forward or quietly dies.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
Where this bill is in the process
Introduced
Introduced in Senate
Senate Committee
Under Senate committee consideration
Latest: Read twice and referred to the Committee on Finance. (6/3/2025)
Senate Floor Vote
Voted on by Senate
Passed Senate
Approved by Senate
House Review
Sent to House for consideration
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your senators when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to Small Biotech Innovation Act, then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it does, where it is in the process (committee), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around S1930, your stance, and the reasons you choose, then lets you edit and send when ready.
